CoChat

Lytic cell death induced by melittin bypasses pyroptosis but induces NLRP3 inflammasome activation and IL-1β release

Open access
Martín-Sánchez, Fátima, Martínez-García, Juan José, Muñoz-García, María, Martínez-Villanueva, Miriam, Noguera-Velasco, José A, Andreu, David, Rivas, Luís, Pelegrín, Pablo · 2017 · Cell Death & Disease
Cited by 46

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The nucleotide-binding domain and leucine-rich repeat-containing receptor with a pyrin domain 3 (NLRP3) inflammasome is a sensor for different types of infections and alterations of homeostatic parameters, including abnormally high levels of the extracellular nucleotide ATP or crystallization of different metabolites. All NLRP3 activators trigger a similar intracellular pathway, where a decrease in intracellular K+ concentration and permeabilization of plasma membrane are key steps. Cationic amphipathic antimicrobial peptides and peptide toxins permeabilize the plasma membrane. In fact, some of them have been described to activate the NLRP3 inflammasome. Among them, the bee venom antimicrobial toxin peptide melittin is known to elicit an inflammatory reaction via the NLRP3 inflammasome in response to bee venom. Our study found that melittin induces canonical NLRP3 inflammasome activation by plasma membrane permeabilization and a reduction in the intracellular K+ concentration. Following melittin treatment, the apoptosis-associated speck-like protein, an adaptor protein with a caspase recruitment domain (ASC), was necessary to activate caspase-1 and induce IL-1 β release. However, cell death induced by melittin prevented the formation of large ASC aggregates, amplification of caspase-1 activation, IL-18 release and execution of pyroptosis. Therefore, melittin-induced activation of the NLRP3 inflammasome results in an attenuated inflammasome response that does not result in caspase-1 dependent cell death.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/cddis.2017.390

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 43

  1. Schroder K, Tschopp J . The inflammasomes. Cell 2010; 140: 821–832. · DOI · Paper page
  2. Compan V, Baroja-Mazo A, López-Castejón G, Gomez AI, Martínez CM, Angosto D et al. Cell volume regulation modulates NLRP3 inflammasome activation. Immunity 2012; 37: 487–500. · DOI · Paper page
  3. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J . Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237–241. · DOI · Paper page
  4. Palm NW, Medzhitov R . Role of the inflammasome in defense against venoms. Proc Natl Acad Sci USA 2013; 110: 1809–1814. · DOI · Paper page
  5. De Torre C, Mesa del Castillo P, Pelegrin P . The NLRP3 and Pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases. Front Immunol 2017; 8: 43.
  6. Próchnicki T, Mangan MS, Latz E . Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation. F1000Res 2016; 5: 1–15. · DOI · Paper page
  7. Pelegrin P . Many ways to dilate the P2X7 receptor pore. Br J Pharmacol 2011; 163: 908–911. · DOI
  8. Dick MS, Sborgi L, Rühl S, Hiller S, Broz P . ASC filament formation serves as a signal amplification mechanism for inflammasomes. Nat Commun 2016; 7: 11929. · DOI · Paper page
  9. Cai X, Chen J, Xu H, Liu S, Jiang QX, Halfmann R et al. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 2014; 156: 1207–1222. · DOI · Paper page
  10. Martín-Sánchez F, Diamond C, Zeitler M, Gomez AI, Baroja-Mazo A, Bagnall J et al. Inflammasome-dependent IL-1β release depends upon membrane permeabilisation. Cell Death Differ 2016; 23: 1219–1231. · DOI · Paper page
  11. Zasloff M . Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389–395. · DOI · Paper page
  12. Boman H, Wade D, Boman I, Wåhlin B, Merrifield R . Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Lett 1989; 259: 103–106. · DOI · Paper page
  13. Elssner A, Duncan M, Gavrilin M, Wewers MD . A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol (Baltimore, Md 1950) 2004; 172: 4987–4994. · DOI · Paper page
  14. Tomasinsig L, Pizzirani C, Skerlavaj B, Pellegatti P, Gulinelli S, Tossi A et al. The human Cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. J Biol Chem 2008; 283: 30471–30481. · DOI · Paper page
  15. Müller UR . Insect venoms. Chem Immunol Allergy 2010; 95: 141–156. · DOI · Paper page
  16. Van Den Bogaart G, Guzmán JV, Mika JT, Poolman B . On the mechanism of pore formation by melittin. J Biol Chem 2008; 283: 33854–33857. · DOI · Paper page
  17. Raghuraman H, Chattopadhyay A . Melittin: a membrane-active peptide with diverse functions. Biosci Rep 2007; 27: 189–223. · DOI · Paper page
  18. Subbalakshmi C, Krishnakumari V, Nagaraj R, Sitaram N . Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13-residue peptide indolicidin. FEBS Lett 1996; 395: 48–52. · DOI
  19. Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield R et al. Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity. FEBS Lett 1992; 296: 190–194. · DOI · Paper page
  20. Papo N, Shai Y . Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci 2005; 62: 784–790. · DOI · Paper page
  21. Munoz-Planillo R, Kuffa P, Martinez-Colon G, Smith BL, Rajendiran TM, Nunez G . K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 2013; 38: 1142–1153. · DOI · Paper page
  22. Moon DO, Park SY, Choi YH, Kim ND, Lee C, Kim GY . Melittin induces Bcl-2 and caspase-3-dependent apoptosis through downregulation of Akt phosphorylation in human leukemic U937 cells. Toxicon 2008; 51: 112–120. · DOI
  23. Akita K, Ohtsuki T, Nukada Y, Tanimoto T, Namba M, Okura T et al. Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP-1 cells. J Biol Chem 1997; 272: 26595–26603. · DOI · Paper page
  24. Rinaldi AC, Mangoni ML, Rufo A, Luzi C, Barra D, Zhao H et al. Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles. Biochem J 2002; 368: 91. · DOI · Paper page
  25. Netea MG, Nold-Petry CA, Nold MF, Joosten LAB, Opitz B, Opitz B et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009; 113: 2324–2335. · DOI · Paper page
  26. Gaidt MM, Ebert TS, Chauhan D, Schmidt T, Schmid-Burgk JL, Rapino F et al. Human monocytes engage an alternative inflammasome pathway. Immunity 2016; 44: 833–846. · DOI · Paper page
  27. Oren Z, Hong J, Shai Y . A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J Biol Chem 1997; 272: 14643–14649. · doi:10.1074/jbc.272.23.14643
  28. Yokum TS, Hammer RP, McLaughlin ML, Elzer PH . Peptides with indirect in vivo activity against an intracellular pathogen: selective lysis of infected macrophages. J Pept Res 2002; 59: 9–17. · doi:10.1046/j.1397-002x.2001.10995.x
  29. Gilbert RJC, Serra MD, Froelich CJ, Wallace MI, Anderluh G . Membrane pore formation at protein-lipid interfaces. Trends Biochem Sci 2014; 39: 510–516. · DOI · Paper page
  30. Gutierrez KD, Davis MA, Daniels BP, Olsen TM, Ralli-Jain P, Tait SWG et al. MLKL activation triggers NLRP3-mediated processing and release of IL-1β independently of Gasdermin-D. J Immunol 2017; 198: 2156–2164. · DOI · Paper page
  31. Hu Z, Murakami T, Suzuki K, Tamura H, Kuwahara-Arai K, Iba T et al. Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophages by dual mechanism. PLoS ONE 2014; 9: e85765. · DOI · Paper page
  32. Jin C, Frayssinet P, Pelker R, Cwirka D, Hu B, Vignery A et al. NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy. Proc Natl Acad Sci USA 2011; 108: 14867–14872. · DOI · Paper page
  33. Brydges SD, Broderick L, McGeough MD, Pena CA, Mueller JL, Hoffman HM . Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies. J Clin Invest 2013; 123: 4695–4705. · DOI · Paper page
  34. Canna SW, Girard C, Malle L, de Jesus A, Romberg N, Kelsen J et al. Life-threatening NLRC4-associated hyperinflammation successfully treated with Interleukin-18 inhibition. J Allergy Clin Immunol 2016; 139: 1698–1701. · DOI · Paper page
  35. Doyle SL, Campbell M, Ozaki E, Salomon RG, Salomon RG, Mori A et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med 2012; 18: 791–798. · DOI · Paper page
  36. Melnikov VY, Ecder T, Fantuzzi G, Siegmund B, Lucia MS, Dinarello CA et al. Impaired IL-18 processing protects caspase-1–deficient mice from ischemic acute renal failure. J Clin Invest 2001; 107: 1145–1152. · DOI · Paper page
  37. Perregaux DG, McNiff P, Laliberte R, Conklyn M, Gabel CA . ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J Immunol 2000; 165: 4615–4623. · DOI · Paper page
  38. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995; 267: 2000–2003. · DOI · Paper page
  39. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004; 430: 213–218. · DOI · Paper page
  40. de Torre-Minguela C, Barberà-Cremades M, Gomez AI, Martin-Sanchez F, Pelegrin P . Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process. Sci Rep 2016; 6: 22586. · DOI · Paper page
  41. Compan V, Martin-Sanchez F, Baroja-Mazo A, López-Castejón G, Gomez AI, Verkhratsky A et al. Apoptosis-associated Speck-like protein containing a CARD forms specks but does not activate caspase-1 in the absence of NLRP3 during macrophage swelling. J Immunol 2015; 194: 1261–1273. · DOI · Paper page
  42. Martín-Sánchez F, Diamond C, Zeitler M, Gomez-Sánchez A, Peñalver M, Paszek P et al. Inflammasome-dependent IL-1 β release depends upon membrane permeabilisation. Cell Death Differ 2016; 23: 1219–1231. · DOI · Paper page
  43. Martin-Sanchez F, Compan V, Pelegrin P . Measuring NLR oligomerization III: detection of NLRP3 complex by bioluminescence resonance energy transfer. Methods Mol Biol 2016; 1417: 159–168. · doi:10.1007/978-1-4939-3566-6_10

Cited by

Metadata

Authors
Martín-Sánchez, F., Martínez-García, J. J., Muñoz-García, M., Martínez-Villanueva, M., Noguera-Velasco, J. A., Andreu, D., Rivas, L., & Pelegrín, P.
Venue
Cell Death & Disease
Published
2017-08-10
Volume
8
Issue
8
Pages
e2984-e2984
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2745250364
Cited by
46
References
7
FWCI
1.46
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.